Evidence map›Paper›PMID 41452438›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2026

Purification strategies and impact of surfactant on bacteriophage stability and aggregation.

Estêvão Brasiliense de Souza, Miguel Abreu de Oliveira, Helena Yurevna Caio, Aguinaldo Roberto Pinto, Gislaine Fongaro

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Estêvão Brasiliense de SouzaLaboratory of Applied Immunology, Department of Microbiology Immunology and Microbiology, Federal University of Santa Catarina, Florianopolis, Santa Catarina, Brazil.
Miguel Abreu de OliveiraLaboratory of Applied Immunology, Department of Microbiology Immunology and Microbiology, Federal University of Santa Catarina, Florianopolis, Santa Catarina, Brazil.
Helena Yurevna CaioLaboratory of Applied Virology, Department of Microbiology, Immunology and Microbiology, Federal University of Santa Catarina, Florianopolis, Santa Catarina, Brazil.
Aguinaldo Roberto Pinto *Laboratory of Applied Immunology, Department of Microbiology Immunology and Microbiology, Federal University of Santa Catarina, Florianopolis, Santa Catarina, Brazil.
Gislaine Fongaro *Laboratory of Applied Virology, Department of Microbiology, Immunology and Microbiology, Federal University of Santa Catarina, Florianopolis, Santa Catarina, Brazil. gislainefongaro@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacteriophages are promising bactericidal agents with potential for infection control, but purification methods and long-term storage can compromise their stability. Viral particle aggregation is a known cause of viability loss and may be reduced with surfactants such as Tween 20. This study evaluated the relationship between aggregation and infectivity loss in MS2 and PhiX174 purified by chloroform clarification and PEG concentration, with or without Tween 20, and by Triton X-100, over 55 days. Infectivity and aggregation varied by purification method, but no direct correlation emerged. MS2 and PhiX174 responded differently, indicating that stability protocols must be virus-specific.

Indexed as

Bacteriophage phi X 174BacteriophagesLevivirusSurface-Active AgentsOctoxynolPolyethylene GlycolsPolysorbatesOctoxynolPolyethylene GlycolsPolysorbatesSurface-Active AgentsAggregationBacteriophagesPurificationStabilityStorageSurfactant

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.